HLBBF
Price
$5.35
Change
-$0.39 (-6.79%)
Updated
Jun 20 closing price
Capitalization
4.85B
HYEX
Price
$1.60
Change
+$0.03 (+1.91%)
Updated
Jun 25 closing price
Capitalization
19.36M
Interact to see
Advertisement

HLBBF vs HYEX

Header iconHLBBF vs HYEX Comparison
Open Charts HLBBF vs HYEXBanner chart's image
H. Lundbeck A/S
Price$5.35
Change-$0.39 (-6.79%)
Volume$176
Capitalization4.85B
HEALTHY EXTRACTS
Price$1.60
Change+$0.03 (+1.91%)
Volume$1K
Capitalization19.36M
HLBBF vs HYEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HLBBF vs. HYEX commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLBBF is a Hold and HYEX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (HLBBF: $5.35 vs. HYEX: $1.60)
Brand notoriety: HLBBF and HYEX are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HLBBF: 87% vs. HYEX: 124%
Market capitalization -- HLBBF: $4.85B vs. HYEX: $19.36M
HLBBF [@Pharmaceuticals: Other] is valued at $4.85B. HYEX’s [@Pharmaceuticals: Other] market capitalization is $19.36M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLBBF’s FA Score shows that 0 FA rating(s) are green whileHYEX’s FA Score has 0 green FA rating(s).

  • HLBBF’s FA Score: 0 green, 5 red.
  • HYEX’s FA Score: 0 green, 5 red.
According to our system of comparison, both HLBBF and HYEX are a bad buy in the long-term.

Price Growth

HLBBF (@Pharmaceuticals: Other) experienced а -6.79% price change this week, while HYEX (@Pharmaceuticals: Other) price change was -8.57% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.88%. For the same industry, the average monthly price growth was +13.85%, and the average quarterly price growth was +92.40%.

Reported Earning Dates

HYEX is expected to report earnings on Apr 01, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.88% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
HLBBF($4.85B) has a higher market cap than HYEX($19.4M). HLBBF YTD gains are higher at: -13.008 vs. HYEX (-36.252). HLBBF has higher annual earnings (EBITDA): 2.94B vs. HYEX (-1.44M). HLBBF has more cash in the bank: 2.88B vs. HYEX (213K). HYEX has less debt than HLBBF: HYEX (1.08M) vs HLBBF (5.22B). HLBBF has higher revenues than HYEX: HLBBF (18.9B) vs HYEX (2.32M).
HLBBFHYEXHLBBF / HYEX
Capitalization4.85B19.4M24,985%
EBITDA2.94B-1.44M-204,464%
Gain YTD-13.008-36.25236%
P/E Ratio13.25N/A-
Revenue18.9B2.32M816,415%
Total Cash2.88B213K1,353,052%
Total Debt5.22B1.08M481,919%
FUNDAMENTALS RATINGS
HYEX: Fundamental Ratings
HYEX
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
53
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ASCYX10.56N/A
N/A
Alger Small Cap Growth Y
PGSLX11.61N/A
N/A
Principal Global Listed Inf Inst
FMPAX28.42N/A
N/A
Fidelity Advisor Mid Cap Value A
JEEDX16.63N/A
N/A
JHancock Infrastructure R6
LGLSX49.71N/A
N/A
Lord Abbett Growth Leaders R4

HLBBF and

Correlation & Price change

A.I.dvisor tells us that HLBBF and HYEX have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HLBBF and HYEX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLBBF
1D Price
Change %
HLBBF100%
N/A
HYEX - HLBBF
21%
Poorly correlated
+1.91%
HLUBF - HLBBF
18%
Poorly correlated
N/A
HLN - HLBBF
10%
Poorly correlated
+0.10%
HLNCF - HLBBF
8%
Poorly correlated
+3.14%
STEK - HLBBF
2%
Poorly correlated
+0.33%
More

HYEX and

Correlation & Price change

A.I.dvisor tells us that HYEX and HLBBF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HYEX and HLBBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYEX
1D Price
Change %
HYEX100%
+1.91%
HLBBF - HYEX
23%
Poorly correlated
N/A
INNPF - HYEX
20%
Poorly correlated
-1.93%
OHCFF - HYEX
10%
Poorly correlated
+5.43%
CLCFF - HYEX
3%
Poorly correlated
N/A
UPC - HYEX
2%
Poorly correlated
+4.71%
More